Julie Refardt

Dr. med.
Julie Refardt

Position(s)
Senior physician

Institution
University Hospital Basel

Phone +41 61 556 56 18

Email

 

Research Focus

Endocrinology, Metabolism & Developmental Disorders

Area of Research

Neuroendocrinology with a focus on neuroendocrine neoplasms and disturbances of the water & salt homeostasis


Approved Research Projects

  • 2022 – 2024: Research Grant Goldschmid-Jacobson Foundation, University of Basel: Neuroendocrine Neoplasms Methylation based Classifier (NEMESIS-study)
  • 2021: Return Grant University Hospital Basel: Improving Therapeutic Options for Patients with Neuroendocrine Neoplasms
  • 2019 – 2020: Early Postdoc.Mobility Grant Swiss National Science Foundation: Improving Treatment Options for Somatostatin Type 2 Receptor Negative Neuroendocrine Tumor Patients (IMPROVE-NET study)

Collaborations

National Collaborations

  • Prof. Katharina Glatz / Jürgen Hench, Pathology, Universitätsspital Basel
  • PD Dr. Raoul Droeser, Surgery, Universitätsspital Basel
  • Dr. Svenja Nölting & Prof. Felix Beuschlein, Universitätsspital Zürich
  • Prof. Beat Müller, Kantonsspital Aarau
  • Dr. Stefan Fischli, Kantonsspital Luzern
  • PD Dr. Stefan Bilz, Kantonsspital St. Gallen
  • Prof. Anne Zanchi, Universitätsspital Lausanne (CHUV)
  • Prof. Gregor Lindner, Spital Solothurn
  • Prof. Jörg Leuppi, Kantonsspital Liestal


International Collaborations

  • Dr. Hans Hofland, Erasmus Medical Center, Rotterdam, the Netherlands
  • Prof. Ewout Hoorn, Erasmus Medical Center, Rotterdam, the Netherlands
  • Prof. Volker Burst, Uniklinik Köln, Germany
  • Prof. Alessandro Peri, Florence, Italy
  • Prof. Darko Kastelan, University Hospital Centre Zagreb, Croatia

Ongoing Research Projects

  • he NEMESIs-study: Neuroendocrine Neoplasms Methylation based Classifier

In collaboration with Prof. Mirjam Christ-Crain

  • The HIT-study: Targeted correction of plasma sodium levels in hospitalized patients with hyponatremia - a randomized, controlled, parallel-group trial with blinded outcome assessment
  • The CARGOx study: Copeptin after arginine infusion compared to copeptin after hypertonic saline infusion for the differential diagnosis of diabetes insipidus
  • The EMPOWER study: Effects of the SGLT2 inhibitor empagliflozin in patients with euvolemic and hypervolemic hyponatremia – a monocentric randomized double-blind placebo-controlled trial

Research Team

Prof. Mirjam Christ-Crain, MD, PhD

Co-leader of research group

Phone +41 328 70 80
Email

Dr. med. Alexandros Lalos

Research Fellow

Phone +41 61 556 53 72
Email

Sophie Monnerat

MD PhD Student

Phone +41 328 76 08
Email

Joyce Santos de Jesus

Study Nurse

Phone +41 61 328 58 69
Email

Bettina Winzeler, MD

Co-leader of research group

Phone +41 556 50 75
Email

Moira Schmidlin

Research fellow

Phone +41 61 328 58 53
Email

Cemile Bathelt

Study Nurse

Phone +41 61 556 54 07
Email

Nicole Salvisberg

Scientific administrative assistant

Phone +41 61 328 68 09
Email

Prof. Emanuel Christ, MD

Head of interdisciplinary Endocrinology

Phone +41 328 55 22
Email

Laura Potasso, PhD

Research Fellow

Phone +41 61 328 58 76
Email

Nina Hutter

Study Nurse 

Phone +41 61 328 68 26
Email

Deborah Vogt, PhD

Statistician

Phone +41 61 556 52 04
Email